logo

For the Inventor, By the Inventor

Ames, IA, United States of America

Newlink Genetics Corporation

USPTO Granted Patents = 22

% Expired Patents = 50.0



Forward Citations = 60

Loading Chart...
Loading Chart...

43 inventors (with patents filed for the assignee):

goldMedal Firoz Jaipuri (20 out of 21 patents)

silverMedal Mario Mautino (18 out of 19 patents)

bronzeMedal Sanjeev Kumar (14 out of 15 patents)

4.  Jesse Waldo (14 out of 15 patents)

5.  Tanay Kesharwani (8 out of 8 patents)

6.  Nicholas N Vahanian (8 out of 8 patents)

7.  Charles J Link (7 out of 15 patents)

8.  Won-Bin Young (6 out of 6 patents)

9.  Hima Potturi (5 out of 6 patents)

10.  Gabriela Rossi (5 out of 10 patents)

11.  Xiaoxia Zhang (4 out of 4 patents)

12.  Richard Pastor (3 out of 24 patents)

13.  Xingyu Lin (3 out of 6 patents)

14.  Lewis J Gazzard (3 out of 39 patents)

15.  Brendan Parr (3 out of 4 patents)


22 patents:

1. 12583858 - TDO2 inhibitors (2026-03-24),
2. 11827639 - TDO2 and IDO1 inhibitors (2023-11-28),
3. 10800780 - TDO2 Inhibitors (2020-10-13),
4. 10233190 - IDO inhibitors (2019-03-19),
5. 10207990 - Salts and prodrugs of 1-methyl-D-tryptophan (2019-02-19),
6. 10047066 - IDO inhibitors (2018-08-14),
7. 9981973 - Tricyclic compounds as inhibitors of immunosuppression mediated by tryptophan metabolization (2018-05-29),
8. 9850248 - IDO inhibitors (2017-12-26),
9. 9732035 - Salts and prodrugs of 1-methyl-D-tryptophan (2017-08-15),
10. 9617272 - Tricyclic compounds as inhibitors of immunosuppression mediated by tryptophan metabolization (2017-04-11),
11. 9512158 - Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes (2016-12-06),
12. 9388191 - Fused imidazole derivatives useful as IDO inhibitors (2016-07-12),
13. 9260434 - Fused imidazole derivatives useful as IDO inhibitors (2016-02-16),
14. 9174942 - IDO inhibitors (2015-11-03),
15. 9090643 - Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes (2015-07-28),
Company Overview
Newlink Genetics Corporation, based in Ames, Iowa, focuses on the development of innovative immunotherapy solutions for cancer treatment. The company specializes in harnessing the power of the immune system to target and destroy cancer cells, utilizing proprietary technologies that enhance the efficacy of existing therapies. With a commitment to advancing cancer care, Newlink Genetics is dedicated to research and development in the field of oncology, aiming to improve patient outcomes through novel therapeutic approaches.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

22 Patents

#10 in Ames, IA

#89 in Iowa

#15,051 in US

#28,807 in the World

Ames, IA (US)
Ames, IA, United States of America

Newlink Genetics Corporation

Forward Citations = 60

43 inventors:

goldMedal Firoz Jaipuri (20 out of 21 patents)

silverMedal Mario Mautino (18 out of 19 patents)

bronzeMedal Sanjeev Kumar (14 out of 15 patents)

4.  Jesse Waldo (14 out of 15 patents)

5.  Tanay Kesharwani (8 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Newlink Genetics Corporation. Retrieved from https://idiyas.com/company/newlink-genetics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…